Relmada Therapeutics (RLMD) Change in Inventory (2012 - 2013)
Relmada Therapeutics (RLMD) posted quarterly Change in Inventory of -$1565.0 for Q4 2013, down 184.59% year-over-year from $1850.0 in Q4 2012, and down 95.62% quarter-over-quarter from -$800.0 in Q3 2013.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Change in Inventory (2012 - 2013) Analysis & Trends
Relmada Therapeutics (RLMD) has reported Change in Inventory for 2 consecutive years, with -$1565.0 the latest figure, recorded in Q4 2013.
- In Q4 2013, Change in Inventory fell 184.59% year-over-year to -$1565.0; the TTM figure through Nov 2013 stood at -$179.0 (changed N/A YoY), while the FY2013 annual figure was $3236.0, up 559.06% from the prior year.
- Change in Inventory retreated to -$1565.0 in Q4 2013 per RLMD's latest filing, from -$800.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $1865.0 in Q1 2013 and bottomed at -$1565.0 in Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Relmada Therapeutics | 498.39 Mn | 498.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Nov 30, 2013 | -1,565.00 |
| Aug 31, 2013 | -800.00 |
| May 31, 2013 | 321.00 |
| Feb 28, 2013 | 5,280.00 |
| Nov 30, 2012 | 1,850.00 |
| Aug 31, 2012 | 1,348.00 |
| May 31, 2012 | 678.00 |